HK:3320 Stock Latest News
Company AnnouncementsChina Resources Pharma warns investors over scope of unaudited subsidiary results3d ago
Company AnnouncementsChina Resources Boya Posts Sharp Profit Decline in Unaudited Nine-Month Results4d ago
Company AnnouncementsChina Resources Pharma Warns Investors Over Unaudited Subsidiary Results Linked to PRC Note Issuance5d ago
Company AnnouncementsCR Double-Crane Posts Modest Profit Decline but Stronger Liquidity in Nine-Month Unaudited Results6d ago- Company AnnouncementsCR Sanjiu Posts Lower Nine‑Month Profit and Cash Levels in Unaudited Results1w ago
Company AnnouncementsChina Resources Pharma Discloses Nine-Month Unaudited Results of Dong-E-E-Jiao1w agoCompany AnnouncementsChina Resources Pharmaceutical Subsidiary Tasly Posts Higher Profit on Lower Revenue1w ago
Company AnnouncementsCR Jiangzhong Posts Lower Revenue, Profit and Cash in Unaudited Nine-Month Results1w ago
Company AnnouncementsChina Resources Pharma Warns as KPC Swings to Loss on Revenue Slump1w ago
Company AnnouncementsChina Resources Pharma Raises RMB800 Million in Third Tranche of 2026 Medium-Term Notes1w ago
Company AnnouncementsChina Resources Pharmaceutical Raises RMB900 Million in Second Tranche of 2026 PRC Bonds2w ago- Company AnnouncementsChina Resources Pharma Subsidiary Starts Pre-Bidding for Potential Share Issuance2w ago
Company AnnouncementsChina Resources Pharma Subsidiary KPC Wins Approval for RMB1 Billion Medium-Term Note Program2M agoCompany AnnouncementsChina Resources Pharma unit posts H1 2026 unaudited results tied to onshore bond issues2M ago
Company AnnouncementsCR Pharmaceutical subsidiary posts unaudited interim results tied to PRC bond issuance2M ago
- Company AnnouncementsChina Resources Pharmaceutical Posts Stable Interim Profit and Higher Revenue2M ago
- Company AnnouncementsChina Resources Pharmaceutical Declares Interim Dividend with Currency Option2M ago
Company AnnouncementsChina Resources Pharma Flags Sharp Interim Loss at KPC Subsidiary2M ago- Company AnnouncementsCR Sanjiu H1 2026 Profit Declines Amid Modest Revenue Growth, Dividend Proposed2M ago
Company AnnouncementsTasly Pharmaceutical Posts Strong Profit and Cash Flow Despite Flat Revenue2M agoCompany AnnouncementsCR Jiangzhong Posts Lower Interim Earnings but Boosts Operating Cash Flow and Keeps Dividend2M ago
Company AnnouncementsCR Double-Crane Posts Softer Interim Earnings but Maintains Dividend Payout2M ago